BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
Por:
Sureda, BM, Torres, JMS, Dols, MC, Bueno, MTM, Gonzalez-Larriba, JL, Aranda, ICB, Carpeno, JD, Iglesias, L, Munoz, MA, Vivanco, GL, Casado, MDI, Lopez, R, Bataller, RD, Abreu, DR, Artal-Cortes, A, Esteban, E, Provencio, M, Pereira, E, Sanchez-Paya, J and Rosell, R
Publicada:
1 oct 2019
Resumen:
Filiaciones:
Sureda, BM:
Hosp Gen Univ Alicante, Dept Med Oncol, Alicante, Spain
Torres, JMS:
Hosp Univ La Princesa, Med Oncol, Madrid, Spain
Dols, MC:
Hosp Reg Univ Malaga, Med Oncol, Malaga, Spain
Bueno, MTM:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Dept Med Oncol, Barcelona, Spain
Gonzalez-Larriba, JL:
Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain
Aranda, ICB:
Univ Hosp Reina Sofia, Dept Med Oncol, Cordoba, Spain
Carpeno, JD:
Hosp Univ La Paz, Med Oncol, Madrid, Spain
Iglesias, L:
Univ Hosp 12 Octubre, Oncol, Madrid, Spain
Munoz, MA:
IVO Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain
Vivanco, GL:
Hosp Univ Cruces, Med Oncol, Baracaldo, Spain
Casado, MDI:
Hosp Clin Univ Lozano Blesa, Med Oncol, Zaragoza, Spain
Lopez, R:
Hosp Clin Univ Santiago CHUS, Med Oncol, Santiago De Compostela, Spain
Bataller, RD:
Hosp Prov Castellon, Med Oncol, Castellon De La Plana, Spain
Abreu, DR:
Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Canary Islands, Spain
Artal-Cortes, A:
Hosp Miguel Servet, Dept Med Oncol, Zaragoza, Spain
Esteban, E:
Hosp Univ Cent Asturias, Med Oncol, Oviedo, Spain
Provencio, M:
Hosp Univ Puerta de Hierro Majadahonda, Med Oncol, Madrid, Spain
Pereira, E:
Spanish Lung Canc Grp Off, Off Management, Barcelona, Spain
Sanchez-Paya, J:
ISABIAL, Epidemiol, Alicante, Spain
:
Inst Healh Sci Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain
|